Image

A Post-market Observational ORIGIN® CR Clinical Study

A Post-market Observational ORIGIN® CR Clinical Study

Recruiting
18-99 years
All
Phase N/A

Powered by AI

Overview

The study objective is to evaluate safety and performance of the ORIGIN® CR (cruciate retaining) devices and associated instruments, more precisely to evaluate safety by the proportion of patients requiring a revision (i.e. revision rate) at 1-year post procedure and to evaluate performance by means of a Knee Society Score (KSS) Knee Score at 1 year post procedure and by means of a KSS Function Score also at 1 year post procedure.

The hypothesis raised for this study, regarding the scoring, is that patients will experience a marked improvement in the natural feel of the prosthesis during the first year after the surgery, and slightly significant improvement at the following interval of 2 years. The overall patient satisfaction is expected to be improved after 2 years follow-up with ORIGIN® CR.

Description

The study is a prospective, non-comparative, non-randomized, single-arm, observational, post market study in which 199 patients will be enrolled to evaluate the safety and performance of the ORIGIN® CR devices and associated instruments.

Patients will be included in the study during 18 months (inclusion window) and followed-up for 24 months.

Eligibility

Inclusion Criteria:

  • Male and female over 18 years of age
  • Each patient who is willing to give informed consent.
  • Clinically indicated for a total knee replacement
  • Females who are not pregnant and not planning to become pregnant ≤ 12 months. A pregnancy test should be performed for women of childbearing age
  • Geographically stable and willing to return to the implanting site for all follow-up visits at 1 year and 2 years.

Exclusion Criteria:

  • Acute or chronic, local or systemic infection
  • Muscular, ligamental, neurological, psychological or vascular deficits
  • Bone destruction or poor bone quality likely to affect implant stability (requiring a femoral and/or a tibial stem and/or a thick insert)
  • Any concomitant condition likely to affect implant integration or function
  • Allergy or hypersensitivity to any of the materials used
  • For devices in CoCrMo (ISO 5832/4): renal and hepatic impairment
  • Hip Knee Ankle (HKA) angle < 165° or > 195°
  • Severe collateral ligaments deficiency (requiring a more constrained prosthesis)
  • Posterior cruciate ligament deficiency
  • Major anatomical deformities
  • Severe flexion contracture or severe recurvatum
  • Revision of a partial or total knee prosthesis
  • Non-extractible material (e.g. screws, plate, intramedullary nail, osteosynthesis material...) which can create a conflict with any component of the prosthesis
  • Distal and/or posterior and/or anterior femoral bone loss which exceeds the femoral component thickness
  • Proximal tibial bone loss which exceeds the tibial component thickness (tibial tray + tibial insert)
  • Bone degradation requiring an anchoring stem for femoral component

Study details
    Total Knee Replacement

NCT05607966

Symbios Orthopedie SA

25 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.